Last reviewed · How we verify

NCT05509114

The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction

Completed NA Last updated 19 August 2022
What this trial tests

NA trial testing Virtual Reality Glasses in Prostate in 70 participants. Completed in 27 July 2022.

Timeline
25 December 2021
Primary endpoint
20 June 2022
27 July 2022

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment70
Start date25 December 2021
Primary completion20 June 2022
Estimated completion27 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 18 to 65, male only, with Prostate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was conducted in a randomized controlled manner to determine the effect of applying virtual reality glasses during transrectal prostate biopsy on pain, anxiety and patient satisfaction.The study was completed with a total of 70 patients, 35 in the intervention group and 35 in the control group, for whom it was decided to perform sample transrectal prostate biopsy for the first time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality Glasses

Trials testing the same drug.

Other recruiting trials for Prostate

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509114.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing